TRIMETHOPRIM ENHANCES THE ANTIBACTERIAL ACTIVITY OF NALIDIXIC AND OXOLINIC ACIDS AND DELAYS THE EMERGENCE OF RESISTANCE

被引：10

作者：

BERTOLINI, A

CASTELLI, M

GENEDANI, S

GARUTI, M

机构：

来源：

EXPERIENTIA | 1980年 / 36卷 / 02期

关键词：

D O I：

10.1007/BF01953757

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：243 / 244

页数：2

共 12 条

[1] INVITRO AND INVIVO STUDIES ON THE COMBINATIONS OF NALIDIXIC AND OXOLINIC ACIDS WITH TRIMETHOPRIM
BERTOLINI, A
CASTELLI, M
GENEDANI, S
BERTONI, V
FORESTA, P
DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1980, 6 (04) : 311 - 316
[2] INVITRO ACTIVITY OF THE CINOXACYN, OXOLINIC ACID, NITROFURANTOIN, NALIDIXIC-ACID AND SULFAMETHOXAZOLE-TRIMETHOPRIM AGAINST ENTEROBACTERIACEAE
MORENO, G
LOPES, CADM
REVISTA BRASILEIRA DE MEDICINA, 1980, 37 (02) : 78 - 84
[3] ACTIVITY OF FLUMEQUINE AGAINST ESCHERICHIA-COLI - INVITRO COMPARISON WITH NALIDIXIC AND OXOLINIC ACIDS
GREENWOOD, D
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 13 (03) : 479 - 483
[4] INVITRO ANTIBACTERIAL ACTIVITY OF NORFLOXACIN, OFLOXACIN AND CIPROFLOXACIN ACCORDING TO RESISTANCE PHENOTYPES TO NALIDIXIC-ACID AND PEFLOXACIN
SOUSSY, CJ
LEVANTHOI, J
DUVAL, J
PATHOLOGIE BIOLOGIE, 1990, 38 (05): : 376 - 384
[5] INVITRO ANTIBACTERIAL ACTIVITY OF A NEW FLUOROQUINOLONE, FLEROXACIN, AS A FUNCTION OF SUSCEPTIBILITY OR RESISTANCE TO NALIDIXIC-ACID AND TO PEFLOXACIN
SOUSSY, CJ
LECLERCQ, R
DEFORGES, L
DUVAL, J
PATHOLOGIE BIOLOGIE, 1989, 37 (05): : 364 - 369
[6] COMPARISON OF THE ACTIVITY AND RATES OF MUTATIONAL RESISTANCE OF MK-0366, OXOLINIC AND NALIDIXIC-ACID AND CINOXACIN ON PSEUDOMONAS-AERUGINOSA AND STAPHYLOCOCCUS-AUREUS
BULLIARD, G
SCHUYTENEER, F
VANDERAUWERA, P
DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1983, 9 (01) : 61 - 65
[7] MET or SHP2 inhibition enhances targeted therapies and delays the emergence of resistance in oncogene-driven NSCLC
Reischmann, Nadine
Pudelko, Lorenz
Stroh, Christopher
Linde, Nina
Musch, Doreen
Keil, Marina
Pudelko, Linda
Esdar, Christina
Blaukat, Andree
Schumacher, Karl M.
Karachaliou, Niki
CANCER RESEARCH, 2022, 82 (12)
[8] CLINICAL-TRIAL OF ANTIBACTERIAL COMBINATION SULFAMOXOLE-TRIMETHOPRIM (CN 3123) .1. EFFICACY - ACTIVITY SPECTRUM - RESISTANCE IN THERAPY
ETZEL, M
WESENBERG, W
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1976, 26 (NA4): : 661 - 665
[9] Mevastatin markedly potentiates the anti-HCV activity of selective inhibitors of HCV replication and delays or prevents the emergence of antiviral resistance
Delang, Leen
Neyts, Johan
ANTIVIRAL RESEARCH, 2008, 78 (02) : A36 - A37
[10] Multifunctional molybdenum disulfide-copper nanocomposite that enhances the antibacterial activity, promotes rice growth and induces rice resistance
Li, Yadong
Liu, Yingliang
Yang, Desong
Jin, Qian
Wu, Cailan
Cui, Jianghu
JOURNAL OF HAZARDOUS MATERIALS, 2020, 394

← 1 2 →